To accelerate vaccine development and optimization, we have developed and characterized an intra-cecal tumor implantation model using tumor fragments derived from a LS mouse model ...

Mar. 13, 2025 — A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States ...

It is possible to have anemia at any stage of colon cancer. Studies suggest anemia is more common with cancers that affect the right side of the colon (cecum, ascending colon, parts of the transverse ...

Throwing a 'Spanner in the Works' of Our Cells' Machinery Could Help Fight Cancer, Fatty Liver Disease... and Hair Loss Apr. 18, 2025 — Fifty years since its discovery, scientists have finally ...

Tumors develop when cells in the body grow uncontrollably. Finding a tumor on your dog can be very frightening, but they are not always detrimental — some are benign, while others are malignant.

Get Instant Summarized Text (Gist) Cell mutations alone are insufficient for tumor formation; additional factors like chronic inflammation are crucial triggers. While mutations can persist without ...

A test to identify higher risk of developing urinary side effects after radiation in patients with prostate cancer was confirmed by data from a new study. Here is a roundup of March 2025 U.S. FDA ...

Adgyl Lifesciences Private Limited, Bangalore, India.

Pheast Therapeutics has begun a phase 1 trial for PHST001, targeting CD24 in advanced solid tumors, to evaluate safety and determine the phase 2 dose. PHST001 has shown promising preclinical results, ...

Tumors develop when cells in the body grow uncontrollably. Finding a tumor on your dog can be very frightening, but they are not always detrimental — some are benign, while others are malignant.

A new high-tech implant has shown "promise" in fighting some of the deadliest forms of cancer. The cancer-fighting device safely triggers "potent" immune responses against hard-to-treat cancers, ...

T1 Tumor limited to the pancreas and size <2 cm T2 Tumor limited to the pancreas and size 2–4 cm T3 Tumor limited to the pancreas and size >4 cm or invading duodenum or bile duct T4 Tumor ...